İbrahim KUTLUBAY, Elif Gülsüm ÜMİT, Jülide TOZKIR

CD247 Genine Ait rs858554 ve rs704848 Polimorfizmlerinin İmmün Trombositopeni Hastalığı ile İlişkisi

DOI: 10.26650/experimed.2019.19007

Anahtar Kelimeler:

İTP, otoimmünite, immün sistem, trombosit, CD247, polimorfizm

The association of CD247 Gene rs858554 and rs704848 Polymorphisms with Immune Thrombocytopenia Disease

DOI: 10.26650/experimed.2019.19007Objective: Immune Thrombocytopenia (ITP) is a disease characterized by the development of thrombocytopenia as a result of platelet destruction due to autoantibodies which is against to platelets. There is the abnormal T cell response that stimulates the proliferation and differentiation of autoreactive B cells. The first signal is transmitted with the CD3 zeta chain (CD247) molecule to the T cell for activation. In this study, the association of immune thrombocytopenia (ITP) disease with rs858554 and rs704848 polymorphisms of CD3 zeta chain (CD247) gene, have been investigated. Materials and Methods: The study was performed with the blood samples taken from 108 donors in the ITP and healthy control group. The patients with ITP who were followed in Trakya University Medical Faculty Hematology Clinic were included to the study. The patients and healthy controls were informed about the study and signed informed consent form approved by the local ethics committee. The ITP group were including 35 females, 20 males (55 in total) and in the healthy control group there were 31 females, 22 males (53 in total). The allelic variants of rs858554 and rs704848 were determined with “TaqMan Probe Real-Time PCR”, the analyses were performed with using “AB Applied Biosystems (SerialNumber: 2720010807)” via VIC/FAM dyes. The results were statistically evaluated with chi square test. Results: According to the results of the study, no significant difference was found in the rs858554 and rs704848 polymorphisms between the ITP group and the healthy control group. Gender distribution and haplotypic situational analysis, and the clinical finding for the ITP patients there were no association with allelic and genotypic variants of polymorphisms. Conclusion: According to the findings that the rs858554 and rs704848 polymorphisms did not directly contribute to the clinical course of ITP disease for the investigated population in this study. This work was supported by Research Fund of the Trakya University. Project Number:2017/05Cite this article as: Kutlubay İ, Ümit EG, Tozkır J. The association of CD247 gene rs858554 and rs704848 polymorphisms with Immune Thrombocytopenia Disease. Experimed 2019; 9(1): 23-7.

Keywords:

ITP, autoimmunity, immune system, platelet, CD247, polymorphism,

PDF

___

1. Bylsma LC, Fryzek JP, Cetin K, Callaghan F, Bezold C, Mehta B, Wasser JS. Systematicliteraturereview of treatments used for adult immune thrombocytopenia in the second-linesetting. Am J Hematol 2019; 94: 118-32. 2. Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program 2018; 2018: 568-75. 3. Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immunethrombocytopenia. Autoimmun Rev 2017; 16: 620-32. 4. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-93. 5. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology. 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-207. 6. Stasi R, Newland AC. ITP: a historical perspective. J Hematol 2011; 153: 437-50. 7. İTP Tanı ve Tedavi Kılavuzu. Türk Hematoloji Derneği, 2011. 8. Grainger JD, Bolton-Maggs PHB, Godeau B, Bussel J, Donato H, Elalfy M, et al. Diagnosis and management of chronic ITP: comments from an ICIS expert group. Ann Hematol 2010; 89: 11-7. 9. Blanchette M, Freedman J. The history of idiopathic thrombocytopenic purpura (ITP). Transfus Sci 1998; 19: 231-6. 10. McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 1978; 239: 2460-2. 11. Abbas AK, Lichtman AH. (2nd ed.). (2004). Basic immunology: functions and disorders of the immune system. Phiadelphia, W.B Saunders Co. 12. Ngoenkam J, Schamel WW, Pongcharoen S. Selected signalling proteins recruited to the T-cell receptor-CD3 complex. Immunology 2018; 153: 42-50. 13. Ahonen T, Saltevo J, Laakso M, Kautiainen H, Kumpusalo E, Vanhala M. Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure. Mediators Inflamm 2009; 2009: 959281. 14. Degner JF, Pai AA, Pique-Regi R, Veyrieras JB, Gaffney DJ, Pickrell JK, et al. DNase I sensitivity QTLs are a majör determinant of human expression variation. Nature 2012; 482: 390-4. 15. Trynka G, Sandor C, Han B, Xu H, Stranger BE, Liu XS, et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nature Genetics 2013; 45: 124-30. 16. Zhang CM, Yu LY, Lv JF, Gong L, Zhou HH, Chen XP, et al. Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell. Per Med 2018 15: 167-79. 17. Li P, Wang X, Zhao MQ, Li LJ, Zhang C, Li BZ, et al. TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis. Autoimmunity 2016; 49: 466-71. 18. Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, et al. Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study. Genes Immun 2015; 16: 142-50.